Literature DB >> 2373126

Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.

B Bengtsson-Hasselgren1, O Rönn, L O Blychert, B Edgar, S Raner.   

Abstract

The acute effects of oral administration of felodipine 10 mg and nifedipine 10 mg on heart rate, blood pressure, forearm blood flow and hepatic blood flow were studied in nine healthy men. Both drugs caused an increase in heart rate of 16 and 7 beats.min-1, respectively. Hepatic blood flow was significantly increased by 1.2 and 0.41.min-1 after felodipine and nifedipine. There was also a decrease in diastolic blood pressure, 10 and 5 mm Hg, respectively, after felodipine and nifedipine. The forearm blood flow was increased by about 30 ml.100 ml-1.min-1 after felodipine, but nifedipine had no effect. The haemodynamic effects were most pronounced 50 min after drug administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373126     DOI: 10.1007/bf00278576

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  The use of indocyanine green for the evaluation of hepatic function and blood flow in man.

Authors:  B D WIEGAND; S G KETTERER; E RAPAPORT
Journal:  Am J Dig Dis       Date:  1960-05

3.  Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.

Authors:  C K Svensson; D J Edwards; P M Mauriello; S H Barde; A C Foster; R A Lanc; E Middleton; D Lalka
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

4.  Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

Authors:  P A Meredith; H L Elliott; F Pasanisi; A W Kelman; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

5.  Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.

Authors:  R D Magorien; D W Triffon; C E Desch; W H Bay; D V Unverferth; C V Leier
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

6.  Nifedipine: kinetics and dynamics in healthy subjects.

Authors:  C H Kleinbloesem; P van Brummelen; J A van de Linde; P J Voogd; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

7.  Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik
Journal:  J Hypertens       Date:  1983-08       Impact factor: 4.844

8.  Acute haemodynamic effects of felodipine and verapamil in man, singly and with metoprolol.

Authors:  O Rönn; B Bengtsson; B Edgar; S Raner
Journal:  Drugs       Date:  1985       Impact factor: 9.546

9.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  11 in total

1.  Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Authors:  P A Soons; T Ankermann; D D Breimer; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet.

Authors:  B Hasselgren; O Rönn; B Edgar; P Johansson; B Wall
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

3.  Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions.

Authors:  Ben D Snyder; Andrew Rowland; Thomas M Polasek; John O Miners; Matthew P Doogue
Journal:  Eur J Clin Pharmacol       Date:  2014-07-17       Impact factor: 2.953

4.  Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years.

Authors:  M Anthracopoulos; A Karatza; E Liolios; M Triga; K Triantou; K Priftis
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

5.  Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.

Authors:  J Burggraaf; R G Westendorp; J C in't Veen; R C Schoemaker; P J Sterk; A F Cohen; G J Blauw
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 6.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 7.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 8.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

9.  The influence of nifedipine and captopril on liver blood flow in healthy subjects.

Authors:  J Burggraaf; R C Schoemaker; J M Kroon; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 10.  Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy.

Authors:  Stephan Walrand; Michel Hesse; Philippe d'Abadie; François Jamar
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.